These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 33040742)

  • 1. Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
    Mamishi S; Navaeian A; Shabanian R
    Cardiol Young; 2021 Jan; 31(1):132-134. PubMed ID: 33040742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
    Orbak Z; Laloglu F; Akat H
    Cardiol Young; 2021 Mar; 31(3):507-510. PubMed ID: 33183365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
    Rodriguez-Garcia JL; Sanchez-Nievas G; Arevalo-Serrano J; Garcia-Gomez C; Jimenez-Vizuete JM; Martinez-Alfaro E
    Rheumatology (Oxford); 2021 Jan; 60(1):399-407. PubMed ID: 33020836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
    Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we use hydroxychloroquine to treat COVID-19 now?
    Chen J; Liu D; Yin L; Zhang L; Lu H
    Int J Antimicrob Agents; 2021 Jan; 57(1):106173. PubMed ID: 33408016
    [No Abstract]   [Full Text] [Related]  

  • 6. Azithromycin, a questionable treatment for COVID-19.
    Belfaqeeh O; Janapala RN; Patel J; Alhashmi A; Pourmand A
    Int J Antimicrob Agents; 2021 Mar; 57(3):106280. PubMed ID: 33476733
    [No Abstract]   [Full Text] [Related]  

  • 7. What if COVID-19 affects the child: which weapons and how to use them.
    Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
    Daneshpazhooh M; Soori T; Isazade A; Noormohammadpour P
    J Dermatolog Treat; 2020 Aug; 31(5):446-447. PubMed ID: 32363963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection.
    Barrachina-Esteve O; Palau Domínguez A; Hidalgo-Torrico I; Viguera Martínez ML
    Neurologia (Engl Ed); 2020; 35(9):710-712. PubMed ID: 32891435
    [No Abstract]   [Full Text] [Related]  

  • 11. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A
    Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
    Hong W; Park YK; Kim BO; Park SK; Shin J; Jang SP; Park HW; Yang W; Jang J; Jang SW; Hwang TH
    PLoS One; 2022; 17(5):e0267645. PubMed ID: 35507600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.
    Jimenez-Cauhe J; Ortega-Quijano D; Carretero-Barrio I; Suarez-Valle A; Saceda-Corralo D; Moreno-Garcia Del Real C; Fernandez-Nieto D
    Clin Exp Dermatol; 2020 Oct; 45(7):892-895. PubMed ID: 32385858
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
    Gourieux B; Reisz F; Belmas AS; Danion F; Fourtage M; Nai T; Reiter-Schatz A; Ruch Y; Walther J; Nivoix Y; Michel B
    Eur J Hosp Pharm; 2021 Sep; 28(5):242-247. PubMed ID: 33239282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    Zequn Z; Yujia W; Dingding Q; Jiangfang L
    Eur J Pharmacol; 2021 Feb; 893():173813. PubMed ID: 33345848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
    Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
    Herth FJF; Sakoulas G; Haddad F
    Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.